These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 26946874)
21. p16/Ki67 dual stain triage versus cytology in primary human papillomavirus-based cervical cancer screening with limited genotyping. Trzeszcz M; Mazurec M; Jach R; Mazurec K; Kotkowska-Szeps I; Kania M; Wantuchowicz M; Wasowska J; Duczek-Polakiewicz M; Rozmus P; Streb J; Halon A J Med Virol; 2023 Nov; 95(11):e29271. PubMed ID: 38009626 [TBL] [Abstract][Full Text] [Related]
22. Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1-2 lesions. Li Y; Liu J; Gong L; Sun X; Long W Virol J; 2019 Oct; 16(1):117. PubMed ID: 31619262 [TBL] [Abstract][Full Text] [Related]
23. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS. Zhu Y; Ren C; Yang L; Zhang X; Liu L; Wang Z BMC Cancer; 2019 Mar; 19(1):271. PubMed ID: 30917784 [TBL] [Abstract][Full Text] [Related]
24. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H]. Wu Y; Zhao J; Hu J; Wu XW; Zhu LR Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267 [No Abstract] [Full Text] [Related]
25. Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus. Longatto Filho A; Utagawa ML; Shirata NK; Pereira SM; Namiyama GM; Kanamura CT; Santos Gda C; de Oliveira MA; Wakamatsu A; Nonogaki S; Roteli-Martins C; di Loreto C; Mattosinho de Castro Ferraz Mda G; Maeda MY; Alves VA; Syrjänen K Int J Gynecol Pathol; 2005 Apr; 24(2):118-24. PubMed ID: 15782067 [TBL] [Abstract][Full Text] [Related]
26. Correlation between P16/Ki67 in cervical cytology and diagnosis of cervical intraepithelial neoplasia 2-3 in Thai women infected with high-risk types of human papillomavirus. Srisuttayasathien M; Kantathavorn N; Luasiripanthu T; Petchjorm S; Samrarn J; Ittiamornlert P; Krisorakun W; Vanichtantikul A; Wetcho T; Saeloo S Taiwan J Obstet Gynecol; 2024 Mar; 63(2):192-198. PubMed ID: 38485314 [TBL] [Abstract][Full Text] [Related]
27. High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study. Tsoumpou I; Valasoulis G; Founta C; Kyrgiou M; Nasioutziki M; Daponte A; Koliopoulos G; Malamou-Mitsi V; Karakitsos P; Paraskevaidis E Gynecol Oncol; 2011 Apr; 121(1):49-53. PubMed ID: 21194734 [TBL] [Abstract][Full Text] [Related]
28. Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study. Razmpoosh M; Sansregret A; Oligny LL; Patey N; Dormoy-Raclet V; Ducruet T; Bouron-Dal Soglio D Am J Clin Pathol; 2014 Jul; 142(1):104-10. PubMed ID: 24926093 [TBL] [Abstract][Full Text] [Related]
29. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women. Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982 [TBL] [Abstract][Full Text] [Related]
30. Predictive value of the combined p16 and Ki-67 immunocytochemistry in low-grade squamous intraepithelial lesions. Ziemke P; Marquardt K; Griesser H Acta Cytol; 2014; 58(5):489-94. PubMed ID: 25342512 [TBL] [Abstract][Full Text] [Related]
31. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies. Nieh S; Chen SF; Chu TY; Lai HC; Lin YS; Fu E; Gau CH Gynecol Oncol; 2005 Apr; 97(1):35-40. PubMed ID: 15790434 [TBL] [Abstract][Full Text] [Related]
32. The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL. Possati-Resende JC; Fregnani JH; Kerr LM; Mauad EC; Longatto-Filho A; Scapulatempo-Neto C PLoS One; 2015; 10(7):e0134445. PubMed ID: 26230097 [TBL] [Abstract][Full Text] [Related]
33. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China. Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727 [TBL] [Abstract][Full Text] [Related]
34. Characterization of cervical biopsies of women with HIV and HPV co-infection using p16 Kremer WW; Vink FJ; van Zummeren M; Dreyer G; Rozendaal L; Doorbar J; Bleeker MCG; Meijer CJLM Mod Pathol; 2020 Oct; 33(10):1968-1978. PubMed ID: 32249820 [TBL] [Abstract][Full Text] [Related]
35. Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion. Koo YJ; Hahn HS; Lee IH; Lim KT; Lee KH; Kim HS; Kim TJ; Chun YK; Kim HS; Hong SR Virchows Arch; 2013 Nov; 463(5):689-96. PubMed ID: 24081504 [TBL] [Abstract][Full Text] [Related]
36. Sensitivity and specificity values of high-risk HPV DNA, p16/ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL). Frega A; Pavone M; Sesti F; Leone C; Bianchi P; Cozza G; Colombrino C; Lukic A; Marziani R; De Sanctis L; Delli Carpini G; Caserta D; Ciavattini A Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10672-10677. PubMed ID: 31858534 [TBL] [Abstract][Full Text] [Related]
37. [Results of pap smears and immunocytochemical detection of the p16 and Ki67 proteins in women with cervical intraepithelial neoplasia and cervical cancer]. Rokita W; Skawiński D; Zmelonek-Znamirowska A; Kedzia W; Karowicz-Bilińska A; Spaczyński R; Spaczyński M Ginekol Pol; 2012 Nov; 83(11):822-6. PubMed ID: 23379189 [TBL] [Abstract][Full Text] [Related]
38. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing. Zhang G; Yang B; Abdul-Karim FW Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189 [TBL] [Abstract][Full Text] [Related]
39. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program. Ovestad IT; Dalen I; Hansen E; Loge JL; Dybdahl BM; Dirdal MB; Moltu P; Berland JM Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650 [TBL] [Abstract][Full Text] [Related]
40. p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study. Schmidt D; Bergeron C; Denton KJ; Ridder R; Cancer Cytopathol; 2011 Jun; 119(3):158-66. PubMed ID: 21442767 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]